Spire Healthcare Group Plc (LSE:SPI), the UK independent hospital group, has reconfirmed its full-year guidance after reporting trading in line with expectations for the four months to April.
The company said it continues to target full-year adjusted EBITDA broadly in line with 2025.
Private patient revenue grew strongly in the period, with self-pay performing particularly well, while NHS revenue came in as expected.
Spire said it had good visibility on NHS volumes for the remainder of the year, with more than 85% of commissioning agreed following the reset of NHS plans in April.
Those volumes are aligned with the company's previously communicated guidance and point to strong growth in the first quarter of financial year 2027, supported by a lower comparative base.
Delivery of the group's £30 million savings target for the year is progressing well, with the majority of initiatives underpinned.
The company's primary care division continues to trade well, with integrated referral activity progressing positively.
Spire issued the update ahead of its annual meeting later on Thursday (May 14).